Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Breast Cancer
•
Medical Oncology
•
Breast Cancer, Non-metastatic
Can tamoxifen be safely prescribed for breast cancer patients with cirrhosis?
Related Questions
Would you treat beyond 10 years of adjuvant hormonal therapy for premenopausal woman with high risk ER+ HER2 negative breast cancer who remain premenopausal at the end of 10 year adjuvant hormonal therapy?
What is your cut off on ER percent positivity to treat breast cancer as functional triple negative cancer?
Does HER2 status or response to neoadjuvant therapy influence your decision to use ovarian function suppression in premenopausal patients with ER+ HER2+ tumors?
Do you offer adjuvant abemaciclib to a high risk young patient desiring more children?
How do you approach the decision for adjuvant chemotherapy in perimenopausal patients with ER+ breast cancer?
How do you manage steroid refractory pneumonitis due to docetaxel or trastuzumab?
How would you approach treatment for local chest wall recurrence while on Anastrozole for a postmenopausal woman with ER+ IDC s/p mastectomy?
How do you treat a patient with TNBC, BRCA WT, who received KEYNOTE 522 with residual disease post neoadjuvant therapy?
How would you approach a postmenopausal patient on Letrozole who developed cataracts within the first six months of treatment?
Would you consider giving hormone replacement therapy to a patient with atypical ductal hyperplasia with no alternative options to manage postmenopausal symptoms?
